Related Experiment Video

Updated: Aug 13, 2026

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

Neutralization epitopes of human rhinovirus type 2

G Appleyard1, S M Russell, B E Clarke

  • 1Department of Virology, Wellcome Biotechnology Ltd, Beckenham, Kent, U.K.

The Journal of General Virology
|June 1, 1990
PubMed

Insights

Researchers identified three human rhinovirus (HRV) neutralization sites by analyzing virus escape mutants. Two sites resemble those in HRV-14, while a third is novel, advancing our understanding of HRV immune evasion.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Human rhinovirus (HRV) is a major cause of the common cold.
  • Neutralizing monoclonal antibodies are crucial tools for studying viral entry and immune response.
  • Understanding HRV neutralization sites is key to developing antiviral strategies.

Purpose of the Study:

  • To identify and characterize neutralization sites on the surface of human rhinovirus type 2 (HRV-2).
  • To investigate the relationship between neutralization sites in HRV-2 and HRV-14.
  • To discover novel neutralization sites on HRV-2.

Main Methods:

  • Selection of 51 HRV-2 escape mutants using 14 neutralizing monoclonal antibodies.
  • Cross-resistance analysis of the generated mutants.
  • RNA sequencing and identification of amino acid substitutions in viral proteins.

Main Results:

  • Three distinct neutralization sites on the HRV-2 surface were identified.
  • Two sites show similarities to NIm-IA and NIm-II sites found in HRV-14.
  • Significant differences were observed between HRV-2 and HRV-14 neutralization sites.
  • A novel third neutralization site on HRV-2 was discovered.

Conclusions:

  • The study elucidates key neutralization sites on HRV-2, contributing to the understanding of HRV structure-function relationships.
  • The findings suggest both conserved and divergent mechanisms of neutralization across HRV serotypes.
  • The identification of a novel site opens new avenues for targeted antiviral therapies against HRV infections.

More Related Videos

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

Engineering Antiviral Agents via Surface Plasmon Resonance13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...